488 related articles for article (PubMed ID: 35624210)
1. Epigenetic regulation of T cell exhaustion.
Belk JA; Daniel B; Satpathy AT
Nat Immunol; 2022 Jun; 23(6):848-860. PubMed ID: 35624210
[TBL] [Abstract][Full Text] [Related]
2. De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation.
Ghoneim HE; Fan Y; Moustaki A; Abdelsamed HA; Dash P; Dogra P; Carter R; Awad W; Neale G; Thomas PG; Youngblood B
Cell; 2017 Jun; 170(1):142-157.e19. PubMed ID: 28648661
[TBL] [Abstract][Full Text] [Related]
3. Cell-Intrinsic Barriers of T Cell-Based Immunotherapy.
Ghoneim HE; Zamora AE; Thomas PG; Youngblood BA
Trends Mol Med; 2016 Dec; 22(12):1000-1011. PubMed ID: 27825667
[TBL] [Abstract][Full Text] [Related]
4. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.
McLane LM; Abdel-Hakeem MS; Wherry EJ
Annu Rev Immunol; 2019 Apr; 37():457-495. PubMed ID: 30676822
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and epigenetic regulation of T-cell exhaustion.
Franco F; Jaccard A; Romero P; Yu YR; Ho PC
Nat Metab; 2020 Oct; 2(10):1001-1012. PubMed ID: 32958939
[TBL] [Abstract][Full Text] [Related]
6. Reversing T-cell exhaustion in immunotherapy: a review on current approaches and limitations.
Tabana Y; Moon TC; Siraki A; Elahi S; Barakat K
Expert Opin Ther Targets; 2021 May; 25(5):347-363. PubMed ID: 34056985
[No Abstract] [Full Text] [Related]
7. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms regulating T-cell responses.
Schmidl C; Delacher M; Huehn J; Feuerer M
J Allergy Clin Immunol; 2018 Sep; 142(3):728-743. PubMed ID: 30195378
[TBL] [Abstract][Full Text] [Related]
9. Regulation and Immunotherapeutic Targeting of the Epigenome in Exhausted CD8 T Cell Responses.
Ford BR; Poholek AC
J Immunol; 2023 Apr; 210(7):869-879. PubMed ID: 36947818
[TBL] [Abstract][Full Text] [Related]
10. Cellular and Molecular Mechanisms of CD8
Verdon DJ; Mulazzani M; Jenkins MR
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027962
[TBL] [Abstract][Full Text] [Related]
11. Schrödinger's T Cells: Molecular Insights Into Stemness and Exhaustion.
Gonzalez NM; Zou D; Gu A; Chen W
Front Immunol; 2021; 12():725618. PubMed ID: 34512656
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional and epigenetic regulation of T cell hyporesponsiveness.
Pereira RM; Hogan PG; Rao A; Martinez GJ
J Leukoc Biol; 2017 Sep; 102(3):601-615. PubMed ID: 28606939
[TBL] [Abstract][Full Text] [Related]
13. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.
Hashimoto M; Kamphorst AO; Im SJ; Kissick HT; Pillai RN; Ramalingam SS; Araki K; Ahmed R
Annu Rev Med; 2018 Jan; 69():301-318. PubMed ID: 29414259
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic engineering for optimal chimeric antigen receptor T cell therapy.
Ito Y; Kagoya Y
Cancer Sci; 2022 Nov; 113(11):3664-3671. PubMed ID: 36000807
[TBL] [Abstract][Full Text] [Related]
15. Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade.
Tian W; Qin G; Jia M; Li W; Cai W; Wang H; Zhao Y; Bao X; Wei W; Zhang Y; Shao Q
Front Immunol; 2023; 14():1198551. PubMed ID: 37398674
[TBL] [Abstract][Full Text] [Related]
16. T cell exhaustion.
Wherry EJ
Nat Immunol; 2011 Jun; 12(6):492-9. PubMed ID: 21739672
[TBL] [Abstract][Full Text] [Related]
17. Metabolic programs tailor T cell immunity in viral infection, cancer, and aging.
Møller SH; Hsueh PC; Yu YR; Zhang L; Ho PC
Cell Metab; 2022 Mar; 34(3):378-395. PubMed ID: 35235773
[TBL] [Abstract][Full Text] [Related]
18. PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.
Viramontes KM; Neubert EN; DeRogatis JM; Tinoco R
Front Immunol; 2022; 13():869768. PubMed ID: 35774790
[TBL] [Abstract][Full Text] [Related]
19. Epitherapy and immune checkpoint blockade: using epigenetic reinvigoration of exhausted and dysfunctional T cells to reimburse immunotherapy response.
McGoverne I; Dunn J; Batham J; Tu WJ; Chrisp J; Rao S
BMC Immunol; 2020 Apr; 21(1):22. PubMed ID: 32316916
[TBL] [Abstract][Full Text] [Related]
20. Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.
Ahn E; Youngblood B; Lee J; Lee J; Sarkar S; Ahmed R
J Virol; 2016 Oct; 90(19):8934-46. PubMed ID: 27466420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
